SARS-CoV-2 spike pseudovirion infection in ARPE-19 cells is a dynamin-dependent process that is primarily mediated by LDLR

Researchers reported on lentiviral pseudovirions pseudotyped with SARS-CoV-2.

Women underrepresented in trials of high-risk medical implants: study

Dive Brief: Women are underrepresented in studies of high-risk medical implants, according to a paper published in JAMA Internal Medicine Monday. The analysis of trials published

June 12, 2024

Idorsia reacquires aprocitentan rights from Janssen for $343m – Pharmaceutical Technology

Aprocitentan is currently under review with the US Food and Drug Administration (FDA), with a Prescription Drug User Fee Act (PDUFA) set for 19 December.

September 6, 2023

How expanded methadone access helped Switzerland defuse its drug crisis

You’re reading Part 4 of The War on Recovery, a yearlong investigation into how the U.S. denies lifesaving medications to people with opioid addiction. Read

March 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.